Logo image of EMX

EMX ROYALTY CORP (EMX) Stock Fundamental Analysis

NYSEARCA:EMX - NYSE Arca - CA26873J1075 - Common Stock - Currency: USD

3.13  +0.03 (+0.97%)

After market: 3.2 +0.07 (+2.24%)

Fundamental Rating

3

EMX gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 156 industry peers in the Metals & Mining industry. The financial health of EMX is average, but there are quite some concerns on its profitability. EMX is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

EMX had negative earnings in the past year.
In the past year EMX had a positive cash flow from operations.
EMX had negative earnings in 4 of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: EMX reported negative operating cash flow in multiple years.
EMX Yearly Net Income VS EBIT VS OCF VS FCFEMX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M

1.2 Ratios

Looking at the Return On Assets, with a value of 0.13%, EMX is in line with its industry, outperforming 56.05% of the companies in the same industry.
EMX has a Return On Equity (0.17%) which is comparable to the rest of the industry.
EMX has a Return On Invested Capital of 1.53%. This is comparable to the rest of the industry: EMX outperforms 50.96% of its industry peers.
Industry RankSector Rank
ROA 0.13%
ROE 0.17%
ROIC 1.53%
ROA(3y)-1.01%
ROA(5y)-4.61%
ROE(3y)-1.33%
ROE(5y)-6.3%
ROIC(3y)N/A
ROIC(5y)N/A
EMX Yearly ROA, ROE, ROICEMX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

1.3 Margins

EMX has a better Profit Margin (0.67%) than 60.51% of its industry peers.
With a decent Operating Margin value of 9.93%, EMX is doing good in the industry, outperforming 64.97% of the companies in the same industry.
Industry RankSector Rank
OM 9.93%
PM (TTM) 0.67%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
EMX Yearly Profit, Operating, Gross MarginsEMX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1K 2K

More info and screens

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), EMX is destroying value.
EMX has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, EMX has more shares outstanding
The debt/assets ratio for EMX is higher compared to a year ago.
EMX Yearly Shares OutstandingEMX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
EMX Yearly Total Debt VS Total AssetsEMX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.2 Solvency

An Altman-Z score of 6.99 indicates that EMX is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 6.99, EMX is in the better half of the industry, outperforming 78.34% of the companies in the same industry.
EMX has a Debt/Equity ratio of 0.30. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of EMX (0.30) is worse than 61.15% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF N/A
Altman-Z 6.99
ROIC/WACC0.17
WACC9.02%
EMX Yearly LT Debt VS Equity VS FCFEMX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M

2.3 Liquidity

EMX has a Current Ratio of 8.56. This indicates that EMX is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of EMX (8.56) is better than 89.17% of its industry peers.
EMX has a Quick Ratio of 8.56. This indicates that EMX is financially healthy and has no problem in meeting its short term obligations.
EMX has a Quick ratio of 8.56. This is amongst the best in the industry. EMX outperforms 89.17% of its industry peers.
Industry RankSector Rank
Current Ratio 8.56
Quick Ratio 8.56
EMX Yearly Current Assets VS Current LiabilitesEMX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

More info and screens

5

3. Growth

3.1 Past

EMX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 107.75%, which is quite impressive.
The Revenue has decreased by -1.62% in the past year.
EMX shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 40.11% yearly.
EPS 1Y (TTM)107.75%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%158.08%
Revenue 1Y (TTM)-1.62%
Revenue growth 3Y42.76%
Revenue growth 5Y40.11%
Sales Q2Q%34.97%

3.2 Future

The Earnings Per Share is expected to grow by 63.03% on average over the next years. This is a very strong growth
EMX is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.70% yearly.
EPS Next Y200%
EPS Next 2Y82.57%
EPS Next 3Y63.03%
EPS Next 5YN/A
Revenue Next Year-7.81%
Revenue Next 2Y1.93%
Revenue Next 3Y6.7%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
EMX Yearly Revenue VS EstimatesEMX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 10M 20M 30M
EMX Yearly EPS VS EstimatesEMX Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 0.05 -0.05 0.1 -0.1 -0.15

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Forward Earnings ratio is 103.91, which means the current valuation is very expensive for EMX.
EMX's Price/Forward Earnings ratio is in line with the industry average.
EMX's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 37.64.
Industry RankSector Rank
PE N/A
Fwd PE 103.91
EMX Price Earnings VS Forward Price EarningsEMX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of EMX is on the same level as its industry peers.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 50.08
EMX Per share dataEMX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 0.4 0.6

4.3 Compensation for Growth

EMX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
EMX's earnings are expected to grow with 63.03% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y82.57%
EPS Next 3Y63.03%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for EMX!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

EMX ROYALTY CORP

NYSEARCA:EMX (7/25/2025, 8:04:00 PM)

After market: 3.2 +0.07 (+2.24%)

3.13

+0.03 (+0.97%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)05-11 2025-05-11/amc
Earnings (Next)08-18 2025-08-18
Inst Owners17.57%
Inst Owner Change-6.98%
Ins Owners14.98%
Ins Owner ChangeN/A
Market Cap341.73M
Analysts84.44
Price Target3.52 (12.46%)
Short Float %0.14%
Short Ratio0.29
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.91%
PT rev (3m)5.83%
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 103.91
P/S 15.77
P/FCF N/A
P/OCF 66.02
P/B 4.05
P/tB 4.05
EV/EBITDA 50.08
EPS(TTM)0
EYN/A
EPS(NY)0.03
Fwd EY0.96%
FCF(TTM)-0.03
FCFYN/A
OCF(TTM)0.05
OCFY1.51%
SpS0.2
BVpS0.77
TBVpS0.77
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.13%
ROE 0.17%
ROCE 1.94%
ROIC 1.53%
ROICexc 1.85%
ROICexgc 1.85%
OM 9.93%
PM (TTM) 0.67%
GM N/A
FCFM N/A
ROA(3y)-1.01%
ROA(5y)-4.61%
ROE(3y)-1.33%
ROE(5y)-6.3%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.19
Health
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF N/A
Debt/EBITDA 3.69
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 1.09
Cash Conversion 75.55%
Profit Quality N/A
Current Ratio 8.56
Quick Ratio 8.56
Altman-Z 6.99
F-Score6
WACC9.02%
ROIC/WACC0.17
Cap/Depr(3y)25.77%
Cap/Depr(5y)19.56%
Cap/Sales(3y)6.62%
Cap/Sales(5y)4.87%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)107.75%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%158.08%
EPS Next Y200%
EPS Next 2Y82.57%
EPS Next 3Y63.03%
EPS Next 5YN/A
Revenue 1Y (TTM)-1.62%
Revenue growth 3Y42.76%
Revenue growth 5Y40.11%
Sales Q2Q%34.97%
Revenue Next Year-7.81%
Revenue Next 2Y1.93%
Revenue Next 3Y6.7%
Revenue Next 5YN/A
EBIT growth 1Y-31.7%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year3027.28%
EBIT Next 3Y238.75%
EBIT Next 5YN/A
FCF growth 1Y44.82%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y220.22%
OCF growth 3YN/A
OCF growth 5YN/A